RYAN BURKE: Open Payments
NPI 1194132860 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$684 in 38 payments from 17 companies in 2025. Trend: 2023 $1,246 · 2024 $916 · 2025 $684
Food & beverage: $684
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $306 |
| PFIZER INC. | 2 | $41 |
| Novo Nordisk Inc | 2 | $40 |
| Lilly USA, LLC | 2 | $33 |
| Amgen Inc. | 2 | $29 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Exact Sciences Corporation | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Dexcom, Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
Products named: MOUNJARO, TRELEGY ELLIPTA, ELIQUIS, Wegovy, The Cologuard Plus Collection Kit, SPRAVATO, Dexcom G6 Transmitter, LEQVIO.
Industry payments across ID — which companies pay providers there.
